Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 22, Issue 1, Pages 141-150Publisher
ELSEVIER
DOI: 10.1016/j.intimp.2014.06.031
Keywords
Sesamin; Airway; Fibroblast; TGF-beta 1; alpha-smooth muscle actin; Epithelial-mesenchymal transition (EMT)
Categories
Funding
- Taiwan National Science Council [NSC 101-2320-B-039-057, NSC 100-2632-B-039-001-MY3, NSC 102-2320-B-039-038-MY3, NSC 102-2320-B-039-035]
- Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]
Ask authors/readers for more resources
Airway fibrosis, which is a crucial pathological condition occurring in various types of pulmonary disorders, is characterized by accumulation and activation of fibroblast cells, deposition of extracellular matrix (ECM) proteins, and increase of airway basement membrane. Transforming growth factor beta 1 (TGF-beta 1) is the principal profibrogenic cytokine that is responsible for fibrotic responses. In the present study, we aimed to investigate the antifibrotic effects of the natural polyphenolic compound, sesamin, on TGF-beta 1-induced fibroblast proliferation and activation, epithelial-mesenchymal transition (EMT), and ovalbumin (OVA)-induced airway fibrosis in vivo. We found that sesamin attenuated TGF-beta 1-induced proliferation of cultured lung fibroblasts. Sesamin inhibited TGF-beta 1-stimulated expression of alpha smooth muscle actin (alpha-SMA), suggesting that sesamin plays an inhibitory role in fibroblast activation. Sesamin blocked upregulation of the mesenchymal markers (fibronectin and vimentin) and downregulation of the epithelial marker (E-cadherin), indicating an inhibitory effect on TGF-beta 1-induced EMT in A549 cells. TGF-beta 1-induced Smad3 phosphorylation was also significantly reduced by sesamin in both cultured fibroblast and A549 cells. In the airway fibrosis induced by OVA in mice, sesamin inhibited the accumulation of alpha-SMA-positive cells and expression of collagen I in the airway. Histological studies revealed that sesamin protected against subepithelial fibrosis by reducing myofibroblast activation and collagen accumulation in the ECM. OVA-induced thickening of basement membrane was significantly alleviated in animals receiving sesamin treatments. These results suggest a therapeutic potential of sesamin as an antifibrotic agent. (C) 2014 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available